Technology | February 06, 2007

Injection Used to Visualize Vessels, Organs, Tumors


A low osmolar, nonionic, iodinated contrast agent, the OMNIPAQUE has been used in more than 250 million patients worldwide. Its indications include a broad range of intravascular diagnostic procedures such as coronary angiography, spinal cord imaging and body cavity procedures including shoulder and knee joints. The injection is approved for use in adults and children.

Related Content

News | Contrast Media Injectors

May 3, 2016 — The global market for contrast media injectors is set to increase from $830 million in 2015 to almost $1.8 ...

Home May 03, 2016
Home
Technology | Contrast Media Injectors

October 1, 2015 — Galt Medical has partnered with Health Line International Corp. and launched the Nexus CT Midline ...

Home October 01, 2015
Home
Feature | Contrast Media Injectors | Raissa Rocha and Dave Fornell

There have been several recent advances with contrast media injector technology, including cutting costs by reducing ...

Home February 10, 2015
Home
Feature | Contrast Media Injectors | Dave Fornell

Automated contrast media injectors are used in cardiac imaging to help improve patient safety and enhance image quality ...

Home July 08, 2010
Home
Subscribe Now